Skip to Content Skip to Content

Medical Ethics

Alzheimer’s drug trials target older Californians. Do they understand what they’re signing up for?

Alzheimer’s drug trials target older Californians. Do they understand what they’re signing up for?

Emily Largent of the Perelman School of Medicine supports the FDA’s recommendations that scientists running drug studies consider having an independent monitor such as a clinician unaffiliated with the trial’s sponsor oversee consent procedures. 

Challenges and advances in brain-computer interfaces
3D neuron system model.

The concept of a brain-computer interface was first proposed and experimented upon in the 1970s by Jacques Vidal, who demonstrated that humans could control a cursor on a computer screen using their brain waves.

(iStock /Tatiana Sozonova)

Challenges and advances in brain-computer interfaces

Following FDA approval for tech startups to begin human clinical trials for brain-computer interfacing technologies, Penn Today met with Anna Wexler of the Perelman School of Medicine to discuss the promising possibilities and potential pitfalls of neurotechnology.